Synairgen plc (LON:SNG – Get Free Report) shares crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 5.29 ($0.07) and traded as high as GBX 7.59 ($0.09). Synairgen shares last traded at GBX 6.50 ($0.08), with a volume of 98,403 shares traded.
Synairgen Stock Performance
The company has a quick ratio of 6.35, a current ratio of 6.77 and a debt-to-equity ratio of 0.09. The stock has a market cap of £12.12 million, a P/E ratio of -130.00 and a beta of -2.23. The stock has a fifty day simple moving average of GBX 5.29 and a 200-day simple moving average of GBX 6.22.
Synairgen Company Profile
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
See Also
- Five stocks we like better than Synairgen
- EV Stocks and How to Profit from Them
- The Charles Schwab Company Can Hit New Highs
- How to Invest in Biotech Stocks
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- What is the FTSE 100 index?
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.